glp 1 antagonist GLP-1-directed NMDA receptor antagonism for obesity treatment PDB-101: Molecule of the Month:

L-carnitine tartrate was administered daily for 6 weeks at doses of 2504,000 mg human equivalent dose (HED)

Mori and Pacific peoples were substantially more likely to be hospitalised with a primary diagnosis of gout compared with non-Mori, non-Pacific people

Dulaglutide (Trulicitys active ingredient) reaches steady-state within approximately 5 days, meaning there is minimal GLP-1 interaction concern when starting a new medication

New insights into natural products that target the gut microbiota: effects on the prevention and treatment of colorectal cancer

Consider working with a registered dietitian or health coach to develop personalized strategies that align with your lifestyle and preferences